CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Serologic SARS-CoV-2 screeningWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug831 Elective Cancer Surgery Wiki 1.00

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Serologic Surveillance for SARS-CoV-2 (COVID-19) in a Prospective Cohort of Health Care

The investigators will follow a single prospective cohort of 50 Health Care Workers in the Hospital Italiano de Buenos Aires (Argentina) from May 15th to August 31st 2020 using antibody testing for SARS-CoV-2 IgM and IgG at baseline and every 2 weeks in order to assess the incidence of COVID-19, the prevalence of anti-SARS-CoV-2 antibodies (IgM and IgG) and incidence of reinfection or reactivations of previous COVID-19 using viral gene sequencing in this cohort.

NCT04387890 COVID-19 SARS-CoV 2 Health Personnel Diagnostic Test: Serologic SARS-CoV-2 screening

Primary Outcomes

Description: Patients that has a positive result for IgM or IgG at baseline first test

Measure: Prevalence of anti SARS-CoV-2 antibodies (IgM and IgG) in health personnel

Time: Baseline at study inclussion

Description: Patients that has a positive result for IgM or IgG or PCR during follow up

Measure: COVID-19 incidence through serology-based screening and/or compatible symptoms in health personnel previously known to be unexposed to the virus

Time: During 3 months follow up

Description: Patients with confirmed previous SARS Cov 2 antibodies that reactivate symptomons or new increase in antibodies title during follow up

Measure: Incidence of reactivation/reinfection for COVID-19 in health personnel with a positive serology for SARS-CoV-2

Time: During 3 months follow up


No related HPO nodes (Using clinical trials)